Clinical study on electrophysiological evaluation of asymptomatic neuropathy in alcohol dependence syndrome

 

 

REFERENCES

1. Abel, E. L., Kruger, M. L. and Friedl, J. (1998), How Do Physicians Define “Light,” Moderate,” and “Heavy” Drinking?. Alcoholism: Clinical and Experimental Research, 22: 979–984.
2. Algorithm for neuropathic pain treatment: an evidence-based proposal. Finnerup NB, Otto M, McQuay HJ, Jensen TS, Sindrup SH Pain. 2005 Dec 5; 118(3):289-305
3. Allen, JP; Megan, VN (2003). Assessing alcohol problems: a guide for clinicians and researchers (PDF). Collingdale, PA: Diane Publishing Co. pp. 332–333. ISBN 9780788138294. Retrieved 15 September 2016.
4. Ballin J, Berglund M, Borg S, et al. A 6-month controlled naltrexone study: combined effect with cognitive behavioral therapy in the outpatient treatment of alcohol dependence. Alcoholism: Clinical and Experimental Research. 2003;27:1142–1149. [PubMed]
5. Baltieri DA, de Andrade AG. Efficacy of acamprosate in the treatment of alcohol-dependent outpatients. Revista Brasileira de Psiquiatria. 2003;25:156–159.
6. Banys P. The clinical use of disulfiram (Antabuse): a review. Journal of Psychoactive Drugs. 1988;20:243–260. [PubMed]
7. Brain steroidogenesis mediates ethanol modulation of GABAA receptor activity in rat hippocampus. Sanna E, Talani G, Busonero F, Pisu MG, Purdy RH, Serra M, Biggio G J Neurosci. 2004 Jul 21; 24(29):6521-30
8. Bratisl Lek Listy. 2002;103(1):26-9.Pathogenesis of alcoholic neuropathy. Kucera P1, Balaz M, Varsik P, Kurca E.
9. Davidson, Robin, and Duncan Raistrick. "The Validity of the Short Alcohol Dependence Data (SADD) Questionnaire: a short self‐report questionnaire for the assessment of alcohol dependence." Addiction 81.2 (1986): 217-222.
10. Double-blind, placebo-controlled trial of lamotrigine in combination with other medications for neuropathic pain. Silver M, Blum D, Grainger J, Hammer AE, Quessy S J Pain Symptom Manage. 2007 Oct; 34(4):446-54.
11. Eckardt, Michael J., et al. "Health hazards associated with alcohol consumption." Jama 246.6 (1981): 648-666.
12. Edenberg, H.J. The genetics of alcohol metabolism: Role of alcohol dehydrogenase and aldehyde dehydrogenase variants. Alcohol Research and Health 30(1):5–13, 2007
13. Effect of high-dose thiamine hydrochloride and S-benzoyl-thiamine-O- monophosphate on thiamine-status after chronic ethanol administration. Netzel M, Ziems M, Jung KH, Noll E, Borsch C, Bitsch I Biofactors. 2000; 11(1-2):111-3.
14. Effects of DL-alpha-lipoic acid on peripheral nerve conduction, blood flow, energy metabolism, and oxidative stress in experimental diabetic neuropathy. Stevens MJ, Obrosova I, Cao X, Van Huysen C, Greene DA Diabetes. 2000 Jun; 49(6):1006-15.
15. Kawada T., Inagaki H., Kuratomi Y. The alcohol use disorders identification test: Reliability study of the Japanese version Alcohol, Volume 45, 2011.
16. Larimer, Mary E.; Palmer, Rebekka S.; Marlatt, G. Alan (1999). "Relapse Prevention" (PDF). 23 (2). National Institute on Alcohol Abuse and Alcoholism
17. Masaki T, Mochizuki H, Matsushita S, Yokoyama A, Kamakura K, Higuchi
18. Mayfield, Demmie, Gail McLeod, and Patricia Hall. "The CAGE questionnaire: validation of a new alcoholism screening instrument." American journal of psychiatry 131.10 (1974): 1121-1123.
19. McKnight, J; Nicholls, PG; Loretta, D; Desikan, VK; Lockwood, DNJ; Wilder-Smith, EP; van Brakel, WH; (2010) Reference values for nerve function assessments among a study population in northern India - III: Sensory and motor nerve conduction. Neurology Asia, 15 (1). pp. 39-54. ISSN 1823-6138.
20. Møller, Aage R. "Anatomy and physiology of peripheral nerves." Intraoperative Neurophysiological Monitoring (2006): 221-227.
21. National Institute on Alcohol Abuse and Alcoholism www.niaaa.nih.gov 301–443–386.
22. Neurobiology of Alcohol Dependence Focus on Motivational Mechanisms Nicholas W. Gilpin, Ph.D., and George F. Koob, Ph.D
23. Piccinelli MTessari EBortolomasi M et al. Efficacy of the alcohol use disorders identification test as a screening tool for hazardous alcohol intake and related disorders in primary care: a validity study. BMJ. 1997;314420- 424
24. Pramod Kerkar, MD, FFARCSI Last Modified On: September 25, 2017, Pain Assist Inc